NL-OMON23415尚未招募不适用
Response to influenza vaccination in lymphoma patients treated with CHOP and rituximab.
St. Antonius Ziekenhuis Nieuwegein0 个研究点目标入组 160 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 160
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with non-Hodgkin’s lymphoma, treated with rituximab (with a range of 6-12 cycles) and who are in remission;
- •2. Completion of rituximab therapy in the last twelve months before start of the study;
排除标准
- •1. Completion of rituximab therapy 7-8 months before start of the study;
- •2. Fever at time of vaccination;
研究者
相似试验
进行中（未招募）
不适用
Reponse to vaccination in patients with bonemarrowcancer who are treated with chemotherapy.multiple myelomaEUCTR2012-005713-39-NLSt. Antonius Hospital
已完成
不适用
Response to Influenza Vaccination in Lymphoma Patients Treated With RituximabNon-Hodgkin Lymphoma (NHL)NCT01707628St. Antonius Hospital98
招募中
不适用
Response to Influenza Vaccination in Pediatric Oncology PatientsHematologic MalignancyPediatric CancerTransplant-Related CancerNCT05384288St. Jude Children's Research Hospital150
尚未招募
不适用
Response to vaccination in lymphoma patients treated with CHOP and rituximab.cancer of the lymph nodes1004743810025320LymphomaNL-OMON38294Sint Antonius Ziekenhuis160
撤回
不适用
Vaccination response in lymphoma patients treated with CHOP and rituximabB-cell malignancylymph node cancer1002532010004018NL-OMON32777Sint Antonius Ziekenhuis140